John Watson, DPM
Foot & Ankle Surgery · Glassboro, NJNPI 1619321205
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Liberty Surgical Inc. at 46.1% of the total. Reporting peaked in 2021 at $5,245 and has fallen 53.7% since, to $2,427 in 2025. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $77.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Liberty Surgical Inc.$7K
- Bone Support Inc.$2K
- Zimmer Biomet$2K
- Smith+Nephew$1K
- Stryker$1K
- Arthrex$411
- plus $2K from 19 others
What the payments were for
- Consulting fees$1,50010%
- Speaking & faculty fees$1041%
- Travel & lodging$1,64611%
- Food & beverage$5,46237%
- Education$6,02141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Liberty Surgical Inc. | 8 | $6,794 |
| Bone Support Inc. | 3 | $1,598 |
| Zimmer Biomet | 16 | $1,504 |
| Smith+Nephew | 36 | $1,258 |
| Stryker | 32 | $1,042 |
| Arthrex | 4 | $411 |
| Eclipse Technology Solutions Inc. | 9 | $312 |
| Zyla Life Sciences, Inc. | 33 | $266 |
| Misonix Inc | 9 | $253 |
| AbbVie | 10 | $184 |
| Organogenesis Inc. | 3 | $172 |
| Treace Medical Concepts, Inc. | 3 | $164 |
| GRT US Holding, Inc. | 1 | $120 |
| Johnson & Johnson | 1 | $117 |
| Paratek Pharmaceuticals, Inc. | 7 | $92 |
| KCI USA, Inc. | 4 | $90 |
| Sanara Medtech Inc. | 1 | $79 |
| Lifenet Health | 4 | $74 |
| Medshape, Inc. | 1 | $63 |
| Kerecis Limited | 1 | $56 |
| Acera Surgical, Inc. | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $12 |
| Cashflow Solutions, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CERAMENTBONE VOID FILLER$1,500
- CERAMENT G$1,500
- Trabecular Metal (TM)$617
- STRAVIX MESH$351
- AUGMENT INJECTABLE$275
- GRAFIX PL$239
- PROPHECY$163
- Juggerknotless Soft Anchor$138
- Stratum Foot Plating System$137
- STRAVIX PL$128
- Qutenza$120
- PICO$118
- VA-LCP PLATES & SCREWS$117
- Oasis$110
- Stravix$110
- Apligraf$104
- Dermagraft$104
- Puraply/Affinity/NuTech$104
- TMC PSI CUT GUIDE SYSTEM$103
- ARTHREX$101
How this compares
$14,734 in reported general payments places this provider in the 90th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 43 | $100,571 |
| Cephalexin | 17 | $130 |
| Clindamycin Hcl | 12 | $84 |
| Tramadol Hcl | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,258 | $100,57143 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 542 foot & ankle surgery providers in New Jersey.
Other foot & ankle surgery in Glassboro
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.